Avatrombopag Usage in NSAA

Clinical trial NCT04728789 · UNKNOWN

Trial details

NCT number: NCT04728789
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Aplastic Anemia Drug Effect

Start date: 2021-02-01
Primary completion: 2022-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.